Top

Current Urology Reports

Published in:

14-06-2023 | Transurethral Prostate Resection

Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement

Authors: Patrick Curtin, Christopher Chang, Andre Uflacker

Published in: Current Urology Reports | Issue 9/2023

Abstract

Purpose of Review

Prostatic artery embolization (PAE) is an emerging minimally invasive technique for lower urinary tract symptom reduction from benign prostatic hypertrophy (BPH). While the technique is becoming increasingly popular with patients and interventional radiologists, most urologists remain skeptical of the PAE’s long-term efficacy and comparative success to the gold standard transurethral resection of the prostate.

Recent Findings

PAE has been found in multiple meta-analyses to perform similarly to the gold standard transurethral resection of the prostate (TURP) with regard to patient-driven measures like IPSS and IPSS-QoL, while also performing favorably in objective measurements including Qmax and PVR out to at least 12 months post intervention. Furthermore, PAE has a demonstrated shorter hospital length of stay and fewer adverse events when compared to TURP.

Summary

PAE provides patients with an alternative to transurethral options for the management of LUTS in the setting of bladder outlet obstruction. While long-term evidence demonstrating the durability of PAE is still forthcoming, the procedure has been demonstrated to be safe according to multiple meta-analyses. Patients deserve to be counseled on PAE as an alternative to surgery and made aware that while the overall treatment effect may not be as robust or durable, the procedure carries a favorable adverse event profile that is attractive to patients wishing to avoid a trans-urethral approach.

Carnevale FC, Antunes AA, Da Motta Leal Filho JM, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–361. https://doi.org/10.1007/s00270-009-9727-z.

Demeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia- transarterial polyvinyl alcohol prostate embolization 1. J Vasc Interv Radiol. 2000;11:767–70.CrossRefPubMed

Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686-1697.e8. https://doi.org/10.1016/j.jvir.2016.08.004.CrossRefPubMed

Jh J, Ka M, Borofsky M, et al. Jung JH, McCutcheon KA, Borofsky M, Young S, Golzarian J, Reddy B, Shin TY, Kim MH, Narayan V, Dahm P. Published online 2020. https://doi.org/10.1002/14651858.CD013656.pub2.www.cochranelibrary.com.

Malling B, Røder MA, Brasso K, Forman J, Taudorf M, Lönn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol. 2019;29(1):287–98. https://doi.org/10.1007/s00330-018-5564-2.CrossRefPubMed

Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE. Am Urol Assoc. 2021;(August):1–65. https://www.auanet.org/guidelines/guidelines/benign-prostatic-hyperplasia-(bph)-guideline.

de Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol. 2015;38(4):855–61. https://doi.org/10.1007/s00270-015-1114-3.CrossRefPubMed

Bilhim T, Pereira JA, Fernandes L, Tinto HR, Pisco JM. Angiographic anatomy of the male pelvic arteries. Am J Roentgenol. 2014;203(4):W373–82. https://doi.org/10.2214/AJR.13.11687.CrossRef

Yoon W, Kim J, Jeon Y, Seo J, Park J, Kang K. Pelvic arterial hemorrhage in patients with pelvic fractures: detection with contrast-enhanced CT. Radiographics. 2004;24(6). https://doi.org/10.1148/rg.246045028.

10.

Picel AC, Hsieh TC, Shapiro RM, Vezeridis AM, Isaacson AJ. Prostatic artery embolization for benign prostatic hyperplasia: patient evaluation, anatomy, and technique for successful treatment. Radiographics. 2019;39(5):1526–48. https://doi.org/10.1148/rg.2019180195.CrossRefPubMed

11.

Yamaki KI, Saga T, Doi Y, Aida K, Yoshizuka M. A statistical study of the branching of the human internal iliac artery. Kurume Med J. 1998;45(4):333–340. https://doi.org/10.2739/kurumemedj.45.333.

12.

Zhang G, Wang M, Duan F, et al. Radiological findings of prostatic arterial anatomy for prostatic arterial embolization: preliminary study in 55 Chinese patients with benign prostatic hyperplasia. PLoS One. 2015;10(7):1–8. https://doi.org/10.1371/journal.pone.0132678.CrossRef

13.

Bilhim T, Pereira JA, Tinto HR, et al. Middle rectal artery: myth or reality? Retrospective study with CT angiography and digital subtraction angiography. Surg Radiol Anat. 2013;35(6):517–22. https://doi.org/10.1007/s00276-012-1068-y.CrossRefPubMed

14.

Martins Pisco J, Pereira J, Rio Tinto H, Fernandes L, Bilhim T. How to perform prostatic arterial embolization. Tech Vasc Interv Radiol. 2012;15(4):286–9. https://doi.org/10.1053/j.tvir.2012.09.002.CrossRefPubMed

15.

Moreira AM, de Assis AM, Carnevale FC, Antunes AA, Srougi M, Cerri GG. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Intervent Radiol. 2017;40(10):1490–500. https://doi.org/10.1007/s00270-017-1765-3.CrossRefPubMed

16.

Isaacson AJ, Fischman AM, Burke CT. Technical feasibility of prostatic artery embolization from a transradial approach. Am J Roentgenol. 2016;206(2):442–4. https://doi.org/10.2214/AJR.15.15146.CrossRef

17.

Bhatia S, Harward SH, Sinha VK, Narayanan G. Prostate artery embolization via transradial or transulnar versus transfemoral arterial access: technical results. J Vasc Interv Radiol. 2017;28(6):898–905. https://doi.org/10.1016/j.jvir.2017.02.029.CrossRefPubMed

18.

Desai H, Yu H, Ohana E, Gunnell ET, Kim J, Isaacson A. Comparative analysis of cone-beam CT angiogram and conventional CT angiogram for prostatic artery identification prior to embolization. J Vasc Interv Radiol. 2018;29(2):229–32. https://doi.org/10.1016/j.jvir.2017.09.020.CrossRefPubMed

19.

Bagla S, Rholl KS, Sterling KM, et al. Utility of cone-beam CT imaging in prostatic artery embolization. J Vasc Interv Radiol. 2013;24(11):1603–7. https://doi.org/10.1016/j.jvir.2013.06.024.CrossRefPubMed

20.

Bagla S, Sterling KM. Pitfalls of cone beam computed tomography in prostate artery embolization. Cardiovasc Intervent Radiol. 2014;37(6):1430–5. https://doi.org/10.1007/s00270-014-0982-2.CrossRefPubMed

21.

Yu SCH, Cho C, Hung E, et al. Case-control study of intra-arterial verapamil for intraprostatic anastomoses to extraprostatic arteries in prostatic artery embolization for benign prostatic hypertrophy. J Vasc Interv Radiol. 2017;28(8):1167–76. https://doi.org/10.1016/j.jvir.2017.04.004.CrossRefPubMed

22.

Bilhim T, Pisco J, Campos Pinheiro L, et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol. 2013;24(11):1595-1602.e1. https://doi.org/10.1016/j.jvir.2013.06.003.CrossRefPubMed

23.

Gonçalves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M. Comparative study using 100–300 versus 300–500 μm microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol. 2016;39(10):1372–8. https://doi.org/10.1007/s00270-016-1443-x.CrossRefPubMed

24.

Bilhim T, Pisco J, Pereira JA, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016;281(1):289–300. https://doi.org/10.1148/radiol.2016152292.CrossRefPubMed

25.

Li Q, Duan F, Wang MQ, Zhang GD, Yuan K. Prostatic arterial embolization with small sized particles for the treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia: preliminary results. Chin Med J (Engl). 2015;128(15):2072–7. https://doi.org/10.4103/0366-6999.161370.CrossRefPubMed

26.

Wang MQ, Zhang JL, Xin HN, et al. Comparison of clinical outcomes of prostatic artery embolization with 50-μm plus 100-μm polyvinyl alcohol (PVA) particles versus 100-μm PVA particles alone: a prospective randomized trial. J Vasc Interv Radiol. 2018;29(12):1694–702. https://doi.org/10.1016/j.jvir.2018.06.019.CrossRefPubMed

27.

Camara-Lopes G, Mattedi R, Antunes AA, et al. The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia. Int Braz J Urol. 2013;39(2):222–7. https://doi.org/10.1590/s1677-5538.ibju.2013.02.11.CrossRefPubMed

28.

Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolization for treatment of benign hyperplasia. Am J Roentgenol. 2014;203(4):813–21. https://doi.org/10.2214/AJR.13.11692.CrossRef

29.

Kisilevzky N, Faintuch S. MRI assessment of prostatic ischaemia: best predictor of clinical success after prostatic artery embolisation for benign prostatic hyperplasia. Clin Radiol. 2016;71(9):876–82. https://doi.org/10.1016/j.crad.2016.05.003.CrossRefPubMed

30.

Pisco JM, Rio Tinto H, Campos Pinheiro L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561–72. https://doi.org/10.1007/s00330-012-2714-9.CrossRefPubMed

31.

Jh J, Ka M, Borofsky M, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia (review). Cochrane Database Syst Rev. 2022;3. https://doi.org/10.1002/14651858.CD012867.pub3.www.cochranelibrary.com.

32.

Franco J, Jung J, Imamura M, et al. Minimally invasive treatments for lower urinary tract symptoms inmen with benign prostatic hyperplasia: a network meta-analysis(review). Cochrane Database Syst Rev. 2021;2021(12).

33.

Zumstein V, Betschart P, Vetterlein MW, et al. Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol Focus. 2019;5(6):1091–100. https://doi.org/10.1016/j.euf.2018.09.005.CrossRefPubMed

34.

Jiang Y-L, Qian L-J. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis. BMC Urol. 2019;19(11).

35.

Fu Y, Wen X, Yin Y, Wang C, Mai J. Comparison of effectiveness and postoperative complications of different surgical methods in the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis based on randomized controlled trials. Transl Androl Urol. 2022;11(6):842–58. https://doi.org/10.21037/tau-22-377.CrossRefPubMedPubMedCentral

36.

•• Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183–93. https://doi.org/10.1007/s00270-020-02657-5. Interesting meta-analysis in which PAE was equally efficacious when compared to gold standard TURP in terms of improvement in both objective and subjective categories including IPSS, IPSS-QoL, IIEF-5, and PVR while having a significantly shorter hospital length of stay and fewer adverse events.CrossRefPubMed

37.

Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361. https://doi.org/10.1136/bmj.k2338.

38.

Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82. https://doi.org/10.1111/bju.14249.CrossRefPubMed

39.

•• LaRussa S, Pantuck M, Wilcox Vanden Berg R, Gaffney CD, Askin G, McClure T. Symptomatic improvement of lower urinary tract symptoms of benign prostatic hyperplasia: a comparative systematic review and meta-analysis of 4 different minimally invasive therapies. J Vasc Interv Radiol. 2021;32(9):1328–1340.e11. https://doi.org/10.1016/j.jvir.2021.06.019. Unique article comparing multiple minimally invasive techniques including prostatic artery embolization (PAE), photoselective vaporization (PVP), prostatic urethral lift (PUL), and water vapor thermal therapy (WV). PAE performed significantly better than PUL and WV in IPSS and QOL after 6 months, and was the only modality that showed continued improvement in these measures between 6 and 12 months. Only PAE resulted in improved IIEF.

40.

Costa NV, Torres D, Pisco J, et al. Repeat prostatic artery embolization for patients with benign prostatic hyperplasia. J Vasc Interv Radiol. 2020;31(8):1272–80. https://doi.org/10.1016/j.jvir.2020.04.027.CrossRefPubMed

41.

Gao YA, Huang Y, Zhang R, et al. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate-a prospective, randomized, and controlled clinical trial. Radiology. 2014;270(3):920–8. https://doi.org/10.1148/radiol.13122803.CrossRefPubMed

42.

Alrashidi I, Alahmari F, Garad F, et al. Intraprostatic abscess: an acute complication of prostatic artery embolization. J Vasc Interv Radiol. 2019;30(2):267–9. https://doi.org/10.1016/j.jvir.2018.11.024.CrossRefPubMed

43.

Kisilevzky N, Laudanna Neto C, Cividanes A. Ischemia of the glans penis following prostatic artery embolization. J Vasc Interv Radiol. 2016;27(11):1745–7. https://doi.org/10.1016/j.jvir.2016.06.017.CrossRefPubMed

44.

Laborda A, De Assis AM, Ioakeim I, Sánchez-Ballestín M, Carnevale FC, De Gregorio MA. Radiodermitis after prostatic artery embolization: case report and review of the literature. Cardiovasc Intervent Radiol. 2015;38(3):755–9. https://doi.org/10.1007/s00270-015-1083-6.CrossRefPubMed

45.

Leite LC, de Assis AM, Moreira AM, Harward SH, Antunes AA, Carnevale FC. Prostatic tissue elimination after prostatic artery embolization (PAE): a report of three cases. Cardiovasc Intervent Radiol. 2017;40(6):937–41. https://doi.org/10.1007/s00270-017-1584-6.CrossRefPubMed

46.

Maqboul F, Umranikar S. Retention by sloughed prostatic tissue: a rare complication after prostate artery embolization. J Clin Urol Published online. 2021. https://doi.org/10.1177/20514158211018133.CrossRef

47.

Moreira AM, Marques CFS, Antunes AA, et al. Transient ischemic rectitis as a potential complication after prostatic artery embolization: case report and review of the literature. Cardiovasc Intervent Radiol. 2013;36(6):1690–4. https://doi.org/10.1007/s00270-013-0739-3.CrossRefPubMed

48.

du Pisanie J, Abumoussa A, Donovan K, Stewart J, Bagla S, Isaacson A. Predictors of prostatic artery embolization technical outcomes: patient and procedural factors. J Vasc Interv Radiol. 2019;30(2):233–40. https://doi.org/10.1016/j.jvir.2018.09.014.CrossRefPubMed

49.

Yu SCH, Cho CCM, Hung EHY, Chiu PKF, Yee CH, Ng CF. Prostate artery embolization for complete urinary outflow obstruction due to benign prostatic hypertrophy. Cardiovasc Intervent Radiol. 2017;40(1):33–40. https://doi.org/10.1007/s00270-016-1502-3.CrossRefPubMed

50.

Kenny AG, Pellerin O, Amouyal G, et al. Prostate artery embolization in patients with acute urinary retention. Am J Med. 2019;132(11):e786–90. https://doi.org/10.1016/j.amjmed.2019.04.037.CrossRefPubMed

51.

• Yuan B, Wang Y, Wang MQ, et al. Prostate artery embolization for the treatment of urinary retention caused by large (>80 mL) benign prostatic hyperplasia: results of 21 patients. J Interv Med. 2020;3(3):142–5. https://doi.org/10.1016/j.jimed.2020.07.007. Single center study in which PAE was utilized in prostatomegaly with prostate volume >80mL. There was overall a 95% success rate for catheter removal with spontaneous voiding at 3 months following intervention. This success was maintained out to 12 months post procedure.CrossRefPubMedPubMedCentral

52.

Bhatia S, Sinha VK, Harward S, Gomez C, Kava BR, Parekh DJ. Prostate artery embolization in patients with prostate volumes of 80 ml or more: a single-institution retrospective experience of 93 patients. J Vasc Interv Radiol. 2018;29(10):1392–8. https://doi.org/10.1016/j.jvir.2018.05.012.CrossRefPubMed

53.

Kurbatov D, Russo GI, Lepetukhin A, et al. Prostatic artery embolization for prostate volume greater than 80 cm 3: results from a single-center prospective study. Urology. 2014;84(2):400–4. https://doi.org/10.1016/j.urology.2014.04.028.CrossRefPubMed

54.

De Assis AM, Moreira AM, De Paula Rodrigues VC, et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates> 90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26(1):87–93. https://doi.org/10.1016/j.jvir.2014.10.012.CrossRefPubMed

55.

Bhatia S, Sinha VK, Kava BR, et al. Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores. J Vasc Interv Radiol. 2018;29(1):78-84.e1. https://doi.org/10.1016/j.jvir.2017.08.022.CrossRefPubMed

56.

Bagla S, Smirniotopoulos JB, Orlando JC, Van Breda A, Vadlamudi V. Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. J Vasc Interv Radiol. 2015;26(12):1832–8. https://doi.org/10.1016/j.jvir.2015.08.018.CrossRefPubMed

57.

Kim JI, Brader R, Viprakasit DP, Isaacson AJ. Prostatic artery embolization for the treatment of benign prostatic hyperplasia in the setting of bladder calculi. J Vasc Interv Radiol. 2017;28(2):306–8. https://doi.org/10.1016/j.jvir.2016.10.018.CrossRefPubMed

58.

Meira M, de Assis AM, Moreira AM, Antunes AA, Carnevale FC, Srougi M. Intravesical prostatic protrusion does not influence the efficacy of prostatic artery embolization. J Vasc Interv Radiol. 2021;32(1):106–12. https://doi.org/10.1016/j.jvir.2020.09.023.CrossRefPubMed

Title: Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement
Authors: Patrick Curtin
Christopher Chang
Andre Uflacker
Publication date: 14-06-2023
Publisher: Springer US
Keywords: Transurethral Prostate Resection
Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Published in: Current Urology Reports / Issue 9/2023
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-023-01170-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 9/2023

Contemporary Use of Computed Tomography (CT) Imaging in Suspected Urolithiasis in Pregnancy

Outcome of Mini-PCNL Under Loco-Regional Anesthesia: Outcomes of a Systematic Review

Holmium and Thulium Fiber Laser Safety in Endourological Practice: What Does the Clinician Need to Know?

Imaging Techniques to Differentiate Benign Testicular Masses from Germ Cell Tumors